Analyst Predicts Positive Outlook for Adverum Biotechnologies with Increased Price Target
On February 6, 2024, Graig Suvannavejh, an analyst at Mizuho, expressed his positive outlook on Adverum Biotechnologies (NASDAQ:ADVM) by maintaining ...
Tag: ADVM
Adverum Biotechnologies: Short Interest Decreases and Positive Outlook for Future Growth
Adverum Biotechnologies Witnesses a Significant Decrease in Short Interest Date: July 20, 2023 Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage biotechnology ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
